Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...
Streetwise Reports | May 27, 2019 |

Antibody Developer Taken Out by Gilead at 'Hefty Premium'

The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. In a March 2 research note, BTIG analyst Robert Hazlett reported that Forty Seven Inc. (FTSV:NASDAQ) is being acquired by Gilead Sciences Inc. (GILD:NASDA...
Streetwise Reports | March 5, 2020 |

Biopharma Buys 'Insurance Policy Ahead of First Commercial Launch'

The terms of the financial transaction and the potential reasons for it are discussed in a BTIG report. In a June 26 research note, BTIG analyst Thomas Shrader reported that Esperion Therapeutics Inc. (ESPR:NASDAQ) agreed to an "up to $200 capped, tier...
Streetwise Reports | July 3, 2019 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |

Timber stocks: Buy and watch your money grow on trees

Chances are you've never considered timber stocks in your investing strategy. But if that's the case, then you've been missing out. Timber is a long-term investment that can reward your portfolio in good times, and protect it in bad. In fact, investing in timber has ...
Don Miller | October 28, 2012 |

Overlooked commodity of which China can't get enough

"Virtually every lumber customer we have in the state of Oregon is now cutting for the Chinese market." That quote comes straight from Rick Holley, CEO of Plum Creek Timber ( NYSE: PCL ), the biggest timberland owner in the U.S. The benchmark commodit...
Larsen Kusick | October 28, 2012 |

U.S. Biotech Makes 'The Acquisition We Were Waiting For'

By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. In a March 4 BTIG research note, analyst Thomas Shrader reported that Biogen Inc. (BIIB:NASDAQ) entered into an agreement to acquire Nightstar Therapeutics Pl...
Streetwise Reports | March 7, 2019 |

Pope Resources Shares Rise 35% on Rayonier $554 Million Takeover Bid

Pope Resources LP shares set a new 52-week intraday high price today after the timber resources firm announced that it agreed to be acquired by Rayonier for $554 million, or $126.91 per unit. The transaction is expected to close in mid-year 2020 subject to approval of Pope's u...
Streetwise Reports | January 16, 2020 |

Top Canadian Stocks – May 2022

Picking out the best Canadian stocks to invest in can be a tricky affair. The top stocks in the country are spread across a variety of different industries, and each has their major players and rising stars. Instead, Stockhouse has highlighted some of the top Canadian stoc...
Stockhouse Editorial | July 29, 2019 |

Gold, Silver, & Copper Royalties - A Promising Investment Opportunity

(Location of the drill holes in the High-Grade Silver zone to the SW of Bilbao. Image via Xtierra Inc. Click to enlarge.) Investors have enjoyed a resurgence of mining stocks in 2020 primarily due to the rise of gold and silver prices but for those l...
Stockhouse Editorial | October 30, 2020 |